Bob Bollinger, MD, MPH

Role: 
Director
Raj and Kamla Gupta Professor of Infectious Diseases, Professor of Medicine, Public Health, and Nursing

Dr. Bollinger is the Raj and Kamla Gupta Professor of Infectious Diseases at the Johns Hopkins University (JHU) School of Medicine, and he holds joint appointments in International Health at the Johns Hopkins (JH) Bloomberg School of Public Health, and in Community Public Health at the JH School of Nursing. He is Founding Director of the Center for Clinical Global Health Education (CCGHE), Associate Director for Medicine of the JH Center for Global Health, and serves on the Advisory Team for the Johns Hopkins Precision Medicine Center of Excellence for COVID-19. He is board certified by the American Board of Internal Medicine in internal medicine and infectious diseases. 

Dr. Bollinger has more than 40 years of experience in international public health, clinical research, and education dealing with such global health priorities as HIV/AIDS, malaria, tuberculosis, leprosy, dengue, antibiotic resistant infections and other emerging diseases. His research interests include identifying biological and behavioral risk factors for HIV transmission; characterizing the clinical progression and treatment of HIV and related infections; development/evaluation of novel point-of-care diagnostics and implementation of research projects to optimize healthcare capacity and delivery in resource-limited settings. Working with partners in more than 20 countries, Dr. Bollinger and CCGHE faculty pioneered the development and use of distance learning and the award-winning emocha mobile health platform. He has been invited to participate in public health training programs and expert committees in more than 15 countries. He is former Director of the JHU Fogarty India Program, and he served as a member of the US Presidential Advisory Council for HIV/AIDS (PACHA), the PACHA International Sub-committee, the Institute of Medicine Forum on Public-Private Partnerships for Global Health and Safety, and the NIH Fogarty International Center Advisory Board.

Dr. Bollinger is committed to improving the health of people living in resource-limited communities through clinical research, education, and leadership training. He established health research and education programs in countries throughout Africa, South and Central America, Southeast Asia, and the Middle East. In 1991, he initiated an NIH-funded Indo-US HIV research program in Pune, India, involving the National AIDS Research Institute/ICMR and the BJ Government Medical College. He has served as Principal Investigator for many NIH-supported studies and clinical trials in Pune, including the SWEN study, which led to changes in World Health Organization (WHO) guidelines for treatment of infants born to HIV positive mothers to prevent mother-to-child transmission. Under his 26 years as leader of the Hopkins India Fogarty International Research Training Program, short-term and degree training has been provided to more than 140 visiting Indian scientists at JHU, and in-country training has been provided to more than 2,000 Indian scientists. His commitment to education has been honored with the Johns Hopkins Department of Medicine David M. Levine Excellence in Mentoring Award.

Dr. Bollinger is author of more than 200 peer-reviewed research publications and 15 book chapters, including the first and largest studies of risk factors for HIV transmission in India, the cloning and sequencing of the first HIV viruses from India, the only studies characterizing the primary immune response to HIV in India, and the demonstration of increased risk of HIV acquisition with recent HSV infection and lack of circumcision.

Dr. Bollinger received an undergraduate degree from Haverford College, a Doctor of Medicine from Dartmouth Medical School, and a Master of Public Health from JH Bloomberg School of Public Health. He completed his internal medicine training at the University of Maryland Medical Systems, followed by a post-doctoral fellowship in infectious diseases at JHU School of Medicine.

Research Program Building and Leadership

  • 1981-1982 Member, Dartmouth Medical School Admissions Committee, Hanover, NH
  • 1993: Faculty Advisor, Graduate Program in Vaccine Development Evaluation and Policy Track, Center for Immunization Research, Johns Hopkins Bloomberg School of Public Health
  • 1994-1995: Member, Molecular and Clinical Research Council, Johns Hopkins University, School of Medicine
  • 1999-2000: Member, Review Committee for the Department of International Health, Johns Hopkins Bloomberg School of Public Health
  • 2001: Chair, Hopkins Bioterrorism Clinical Management Working Group Member, Length-of-Stay Committee Johns Hopkins Department of Medicine
  • 2004: Member, Clinical Care Safety and Quality Improvement Committee, Johns Hopkins Department of Medicine
  • 2007: Member, Advisory Committee, Global Health and Foreign Policy Initiative, Johns Hopkins School of Advanced International Studies
  • 2004-2010: Member, Advisory Board, Johns Hopkins Medicine Point of Care Information Technology (POC-IT) Center
  • 2006, 2011: Member, International Health Review Committee, Johns Hopkins Bloomberg School of Public Health
  • 1992-2012: Executive Committee Member, Johns Hopkins University Fogarty International Center Program of International Training Grants in Epidemiology Related to AIDS
  • 2005-2012: Associate Director, Center for Global Health The Johns Hopkins University, Department of Medicine
  • 2008-present: Member, Consortium Working Group, Johns Hopkins, University of Washington, University of California San Francisco, University of Pennsylvania Consortium of Academic Centers Committed to Cross-Disciplinary Global Health Training and Mentorship
  • 2009-present: Member, Infectious Diseases Fellowship Recruitment and Selection Committee, Johns Hopkins University
  • 2011-present: Member, JHU Global mHealth Initiative (GMI), Johns Hopkins Bloomberg School of Public Health
  • 2012-present: Member, Johns Hopkins InHealth, Johns Hopkins Bloomberg School of Public Health
  • 2013-present: Member, Faculty Advisory Committee on International Activities (FACIA), Johns Hopkins University
  • 2013-present: Member, Advisory Board of Centro SOL (Salud/Health and Opportunity for Latinos), Johns Hopkins Bayview
  • 2013-2018: Director, miLab Project with imec and miDiagnostics 
  • 2014-present: Member, Advisory Board Center for Global Initiatives, Johns Hopkins University School of Nursing 
  • 2017-2020: Advisory Board Member, NIH Fogarty International Center 
  • 2017-present: Member, Fogarty African Bioethics Consortium - Post-Doctoral Fellowship (FABC-PDF), Training Advisory Committee, Johns Hopkins International Health
  • 2020-present: Advisory Team Member, Johns Hopkins Precision Medicine Center of Excellence for COVID-19

Visual Field Loss in HIV-Positive Patients of Non-Infectious HIV Retinopathy

Post Date: 
2019-06-02
   |   
Countries: 
India
   |   
Clinical Sites: 
BJGMC
New study will assess HIV+ patients and determine the prevalence of visual field loss due to noninfectious HIV retinopathy

Prevalence of Tuberculosis in Severely Malnourished Indian Children

Post Date: 
2018-12-18
   |   
Countries: 
India
   |   
Clinical Sites: 
BJGMC
This study is funded and conducted under the U.S. National Institutes of Health, Fogarty International Center. PIs are Robert Bollinger, MD, MPH; Dr. Muralidhar Tambe, BJGMC Severely malnourished children are vulnerable population for communicable and non-communicable disease. Diagnosis of TB among...

Characterization of TB-specific T Cell Responses in Highly-exposed, but Uninfected Health Care Workers in India

Post Date: 
2018-10-25
   |   
Countries: 
India
   |   
Clinical Sites: 
BJGMC
This study is funded and conducted under the U.S. National Institutes of Health, Fogarty International Center. PIs are Robert Bollinger, MD, MPH; Jyothi Rengarajan, MD, Emory University. Primary Research Question Do health care workers who remain TST negative, despite high-exposure to TB,...

Assessing the Impact of Psychosocial Involvement in Health Care Workers with and without Active Tuberculosis at the Byramjee Jeejeebhoy Government Medical College, Pune, India

Post Date: 
2018-09-13
   |   
Countries: 
India
   |   
Clinical Sites: 
BJGMC
This study is funded and conducted under the U.S. National Institutes of Health, Fogarty International Center. The overall goal is to understand the psychosocial involvement in health care workers with and without active tuberculosis. The specific aims of this study are: To understand the...

Gut Microbiota of HIV Infected Pregnant Women

Post Date: 
2018-06-14
   |   
Countries: 
India
   |   
Clinical Sites: 
BJGMC
Birth Outcomes in HIV Both antiretroviral-therapy (ART)-naïve and ART-experienced HIV-infected pregnant women have higher incidences of pre-term birth (PTB) compared to HIV-uninfected women. For example, the global prevalence of PTB is around 8%, while the rates in in HIV-infected populations are...

Optimal Approach for TB Screening among HIV Infected Indian Children

Post Date: 
2018-06-11
   |   
Countries: 
India
   |   
Clinical Sites: 
BJGMC
This study was terminated May 20, 2019. It was funded by the Fogarty International Center at the U.S. National Institutes of Health. Determining TB status (ie, uninfected, latent, and active TB disease) is more difficult among children, particularly HIV-infected children. Diagnosis of TB disease is...

Assessing the Impact of the Fogarty HIV-TB Training Program at the Byramjee Jeejeebhoy Government Medical College, Pune, India

Post Date: 
2018-01-19
   |   
Countries: 
India
   |   
Clinical Sites: 
BJGMC
This study was funded by the Fogarty International Center at the U.S. National Institutes of Health. Johns Hopkins University was funded in 2013 to establish a new post-doctoral training program in HIV-TB epidemiology, clinical and laboratory research, for junior faculty of the Byramjee Jeejeebhoy...

Perceptions of HCWs on Barriers and Opportunities to Airborne Infection Control Guideline Implementation

Post Date: 
2017-12-07
   |   
Countries: 
India
   |   
Clinical Sites: 
BJGMC
This study is funded and conducted under the U.S. National Institutes of Health, Fogarty International Center. Led by Dr. Nishi Suryavanshi, this qualitative, cross-sectional study is assessing healthcare worker (HCW) perceptions about barriers and facilitators to the uptake of airborne infection...

The Role of GeneXpert in Bacterial Diagnosis of Spinal Tuberculosis

Post Date: 
2017-10-26
   |   
Countries: 
India
   |   
Clinical Sites: 
BJGMC
This study was teriminated June 19, 2019. It was funded by the Fogarty International Center at the U.S. National Institutes of Health. India has the maximum burden of tuberculosis (TB) in the world. In 2014, there were an estimated 9.6 million incident cases of TB (range, 9.1 million–10.0 million)...

Zika Surveillance among Antenatal Clinic Outpatients in BJ Government Medical College and Sassoon General Hospitals, Pune, India

Post Date: 
2017-08-31
   |   
Countries: 
India
   |   
Clinical Sites: 
BJGMC
This study was terminated July 21, 2020. Zika virus is a vector-borne disease carried by the mosquito Aedes aegypti . Pregnant women infected with Zika may pass the virus to the fetus, which may cause microcephaly and other severe brain defects. It is also linked to miscarriage, stillbirth, and...

Risk Factors for Unfavourable Treatment Outcomes among Multidrug-Resistant Tuberculosis Patients in Public Sector Treatment in Pune

Post Date: 
2017-03-29
   |   
Countries: 
India
This study is funded and conducted under the U.S. National Institutes of Health, Fogarty International Center. This study seeks to identify risk factors associated with unfavourable treatment outcomes (death, treatment failure, default, XDR-TB) among multidrug-resistant tuberculosis (MDR-TB)...

Prevalence and Risk Factors for Oral Cancer among HIV-Infected Adults

Post Date: 
2016-12-13
   |   
Countries: 
India
   |   
Clinical Sites: 
BJGMC
The study is designed as a cross-sectional, single time point study for opportunistic oral cancer screening of HIV-infected and non- HIV adults 21 years or older in an urban hospital. All participants will undergo screening for oral cancer and oral potentially malignant disorders (OPMD) by visual...

Cost-effectiveness of Xpert MTB/RIF for Diagnosing Pulmonary Tuberculosis in HIV-positive Patients

Post Date: 
2016-12-01
   |   
Countries: 
India
   |   
Clinical Sites: 
BJGMC
This study was terminated October 8, 2019. This is a prospective cross-sectional study which will be conducted at BJGMC in Pune, India. The aim of this study is to see whether Xpert MTB/RIF is useful for early detection of pulmonary tuberculosis, and therefore cost-effective, as compared with...

The Evaluation of Clinical Profile and Mortality of Children Admitted with Tuberculosis in Pediatric Intensive-Care Unit at Sassoon General Hospitals, Pune

Post Date: 
2016-10-27
   |   
Countries: 
India
   |   
Clinical Sites: 
BJGMC
This study was terminated October 27, 2019. Tuberculosis (TB) is one of the most common causes of infection-related death globally. TB was declared global public health emergency in 1993 by World HealthOrganization (WHO). Mortality due to TB is increasing due to emergence of multidrug resistant (...

Adherence to Indian National Guidelines for Isoniazid Chemoprophylaxis among Pediatric Contacts of Pulmonary Tuberculosis Cases

Post Date: 
2016-07-06
   |   
Countries: 
India
   |   
Clinical Sites: 
BJGMC
This study was terminated June 19, 2019. The primary objective of the study was to assess the implementation of the Indian Revised National Tuberculosis Programme's (RNTCP) guidelines regarding isoniazid preventive treatment (IPT) for children under 6 years of age who had been in contact with...

A Randomized Therapeutic Interventional Comparative Study between Three Different Modalities of Paediatric Antitubercular Treatment

Post Date: 
2016-06-13
   |   
Countries: 
India
   |   
Clinical Sites: 
BJGMC
This study was terminated July 6, 2019. It was funded by the Fogarty International Center at the U.S. National Institutes of Health. This study evaluated three different TB treatment regimens in children attending Sassoon General Hospital in Pune, India. A convenience sample size of n=100 children...

Optimal Algorithmic Diagnosis of Genital TB among HIV-infected and Uninfected Infertile Women

Post Date: 
2016-05-26
   |   
Countries: 
India
   |   
Clinical Sites: 
BJGMC
This study was terminated March 2020. It was funded by the Fogarty International Center at the U.S. National Institutes of Health. There is a lack of a set protocol universally for diagnosis of genital TB, and for Indian hospitals, India's Revised National Tuberculosis Control Program (RNTCP) also...

Barriers to Early Treatment Initiation in Childhood Tuberculosis in High Incidence Setting

Post Date: 
2016-04-21
   |   
Countries: 
India
   |   
Clinical Sites: 
BJGMC
This study was terminated October 25, 2019. Funded by the Fogarty International Center and led by PI Dr. Chhaya Tukaram Valvi, the aim of this study is to evaluate the time to treatment initiation and barriers to early treatment initiation in childhood tuberculosis. TB diagnosis in children is...

Barriers to Implementation of Isoniazid Preventive Treatment (IPT) in Pediatric Contacts of Sputum Positive Adults with Tuberculosis

Post Date: 
2016-03-24
   |   
Countries: 
India
   |   
Clinical Sites: 
BJGMC
This study was terminated January 3, 2019. It was funded by the Fogarty International Center at the U.S. National Institutes of Health. Young children infected with M.tuberculosis can rapidly progress to pulmonary and extrapulmonary disease with high rates of mortality and morbidity. Studies...

miDOT (Directly Observed Therapy)

Post Date: 
2015-11-01
Designed by Dr. Maunank Shah, the miDOT mobile health application is a video-based Directly Observed Therapy interface that uses the emocha Mobile Health platform to remotely connect patients on long-term tuberculosis therapy with clinicians who are required to witness patients taking...

Pages

Tuberculosis preventive treatment should be considered for all household contacts of pulmonary tuberculosis patients in India

Post Date: 
2020-07-29
   |   
Countries: 
India
   |   
Clinical Sites: 
BJGMC
Publication: 
PLoS One
PLoS One: Dr. Mandar Paradkar and colleagues conducted a CTRIUMPH study that supports TB preventive therapy for all household contacts of pulmonary TB patients in India

Impact of the Fogarty Training Program on Trainee and Institutional Research Capacity Building at a Government Medical College in India

Post Date: 
2020-07-28
   |   
Countries: 
India
   |   
Clinical Sites: 
BJGMC
Publication: 
Annals of Global Health
Gauri Dumal and colleagues assess the impact of the 5-year HIV-TB research training program on building individual research capacity at BJGMC.

A mobile health-facilitated behavioral intervention for community health workers improves exclusive breastfeeding and early infant HIV diagnosis in India: A cluster randomized trial

Post Date: 
2020-07-03
   |   
Countries: 
India
   |   
Clinical Sites: 
BJGMC
Publication: 
Journal of the International AIDS Society
When community health workers used a mobile health intervention with HIV+ women to deliver care, there was a higher uptake of exclusive breastfeeding at two months and early infant HIV diagnosis at six weeks

Acceptability and Feasibility of a Behavioral and Mobile Health Intervention (COMBIND) Shown to Increase Uptake of Prevention of Mother to Child Transmission (PMTCT) Care in India

Post Date: 
2020-05-24
   |   
Countries: 
India
Publication: 
BMC Public Health
A cluster-randomized trial recently demonstrated that an integrated behavioral and mobile technology intervention improved uptake of key components of a Prevention of Mother to Child Transmission (PMTCT) Option B+ program, among HIV- infected pregnant/breastfeeding women in India.

Compliance of private pharmacies in Uganda with controlled prescription drugs regulations: A mixed-methods study

Post Date: 
2020-02-08
   |   
Countries: 
Uganda
Publication: 
Substance Abuse Treatment, Prevention, and Policy
Background: Controlled prescription drug use disorders are a growing global health challenge in Sub-Saharan Africa. Effective supply chain regulations on dispensing and stock control are important for controlling this epidemic. Since compliance with these regulations in resource-limited countries...

Addressing the global burden of hepatitis B virus while developing long-acting injectables for the prevention and treatment of HIV

Post Date: 
2019-12-20
Publication: 
Lancet HIV
Lancet HIV: Dr. Bob Bollinger and colleagues discuss the urgent need and opportunity to include activity against Hepatitis B in formulations of long-acting drugs for HIV prevention and treatment

MAL adaptor (TIRAP) S180L polymorphism and severity of disease among tuberculosis patients

Post Date: 
2019-10-31
   |   
Countries: 
India
   |   
Clinical Sites: 
BJGMC
NIRT
Publication: 
Infection, Genetics, and Evolution
Infection, Genetics, and Evolution : We investigated the association of TIRAP variants with severity of TB disease and IP-10 production in humans, which may be useful in predicting poor clinical outcome

Delays and barriers to early treatment initiation for childhood tuberculosis in India

Post Date: 
2019-10-01
Publication: 
International Journal of Tuberculosis and Lung Disease
BACKGROUND: India accounts for 27% of global childhood tuberculosis (TB) burden. Understanding barriers to early diagnosis and treatment in children may improve care and outcomes. METHODS: A cross-sectional study was performed among 89 children initiated on anti-TB treatment...

Evaluation of miLINC to shorten time to treatment for rifampicin-resistant Mycobacterium tuberculosis

Post Date: 
2019-09-01
Publication: 
The International Journal of Tuberculosis and Lung Disease
A suite of mobile health applications shows promise for linking more drug-resisitant TB patients to care and in less time.

High risk for latent tuberculosis infection among medical residents and nursing students in India

Post Date: 
2019-07-08
   |   
Countries: 
India
   |   
Clinical Sites: 
BJGMC
Publication: 
PLoS One
PLoS ONE: Self-reported TB exposure is underreported, and uptake of LTBI prevention therapy remains low

Users beware! Biological variation in complete blood counts over short time intervals

Post Date: 
2019-05-29
Publication: 
BMJ Evidence Based Medicine
New publication in BMJ Evidence Based Medicine looks at CBC count variations in blood drawn over a short time period

Assessment of lung function in successfully treated tuberculosis reveals high burden of ventilatory defects and COPD

Post Date: 
2019-05-23
   |   
Countries: 
India
Publication: 
PLoS One
New in PLoS One: We found a high burden of lung function defects and COPD in tuberculosis cases who successfully completed treatment, suggesting a need for lung function screening as part of patient management.

Elevated highly sensitive C-reactive protein and d-dimer levels are associated with food insecurity among people living with HIV in Pune, India

Post Date: 
2019-03-04
   |   
Countries: 
India
   |   
Clinical Sites: 
BJGMC
Publication: 
Public Health Nutrition
Abstract OBJECTIVE: To assess the prevalence and determinants of food insecurity among people living with HIV (PLWH) in Pune, India and its association with biomarkers known to confer increased risks of morbidity and mortality in this population. DESIGN:...

Barriers to screening and isoniazid preventive therapy for child contacts of tuberculosis patients

Post Date: 
2018-10-01
   |   
Countries: 
India
   |   
Clinical Sites: 
BJGMC
Publication: 
International Journal of Tuberculosis and Lung Disease
Universal, timely TB screening and IPT for exposed children are urgently needed to reduce pediatric TB in India

Inflammation and micronutrient biomarkers predict clinical HIV treatment failure and incident active TB in HIV-infected adults: a case-control study

Post Date: 
2018-09-24
   |   
Countries: 
India
   |   
Clinical Sites: 
BJGMC
Publication: 
BMC Medicine
Factors identified through exploratory factor analysis were associated with adverse outcomes in HIV-infected individuals.

Challenges and opportunities for outreach workers in the Prevention of Mother to Child Transmission of HIV (PMTCT) program in India

Post Date: 
2018-09-04
   |   
Countries: 
India
Publication: 
PLoS One
PLoS One: Prevention of Mother-to-Child Transmission of HIV program in India is one of the largest in the world, and it relies on outreach workers. Our study looked at challenges and opportunities for outreach workers.

Internal medicine residents' knowledge and practice of pulmonary tuberculosis diagnosis

Post Date: 
2018-06-27
   |   
Countries: 
United States
Publication: 
Open Forum Infectious Diseases
BACKGROUND: Internal medicine physicians are often the first providers to encounter patients with a new diagnosis of tuberculosis. Given the public health risks of missed tuberculosis cases, assessing internal medicine residents' ability to diagnose tuberculosis is important. ...

Loss to follow‐up and mortality among HIV‐infected adolescents receiving antiretroviral therapy in Pune, India

Post Date: 
2018-06-25
   |   
Countries: 
India
   |   
Clinical Sites: 
BJGMC
Publication: 
HIV Medicine
Over 6 years, one-third of HIV+ adolescents in this study discontinued medical treatment, indicating a critical need for retention counselling and closer clinical monitoring.

Developing an assessment framework for essential internal medicine subspecialty topics

Post Date: 
2018-06-15
   |   
Countries: 
United States
Publication: 
Journal of Graduate Medical Education
Our assessment framework revealed knowledge and practice gaps in tuberculosis diagnosis among internal medicine residents.

Diabetes and pre-diabetes among household contacts of tuberculosis patients in India: is it time to screen them all?

Post Date: 
2018-05-22
   |   
Countries: 
India
   |   
Clinical Sites: 
BJGMC
Publication: 
The International Journal of Tuberculosis and Lung Disease
Authors find that screening contacts of TB patients for pre-DM/DM and linking them to care may mitigate the risk of developing tuberculosis and improve management of diabetes.

Pages

Tuberculosis preventive therapy should be considered for all household contacts of pulmonary TB patients in India

Post Date: 
2020-02-07
   |   
Countries: 
India
   |   
Clinical Sites: 
BJGMC
NIRT
Paradkar M, Chandrasekara P, Jain D, Shivakumar SVBY, Thiruvengadan K, Gupte AN, Thomas B, Kinikar A, Sekar K, Bharadwaj R, Dolla CK, Gaikwad S, Elilarasi S, Lokhande R, Reddy D, Murali L, Kulkarni V, Pradhan N, Hanna LE, Pattabiraman S, Kohli R, Nayagam R, Suryavanshi N, Shrinivasa BM, Cox SR,...

Does treatment of infertile women with probable genital tuberculosis improve fertility outcome?

Post Date: 
2019-11-01
   |   
Countries: 
India
   |   
Clinical Sites: 
BJGMC
Naik SN , Chandanwale A, Kadam D, Sambarey PW, Dhumal G, DeLuca A, Jain D, Gupta A, Bollinger R, Mave V. Does treatment of infertile women with probable genital tuberculosis improve fertility outcome? Poster presentation. 50th Union World Conference on Lung Health. Hyderabad, India. October 30-...

IL-6, TIMP-2 and TGFβ-2 Are Associated with Respiratory Impairment During and Following Successful Treatment of Pulmonary Tuberculosis

Post Date: 
2019-02-04
   |   
Countries: 
India
   |   
Clinical Sites: 
BJGMC
NIRT
Gupte A , Paradkar M, Selvaraju S, Kumar P, Lokhande R, Kulkarni V, Hanna LE, Thiruvengadam K, Sekar K, Momin A, Shivakumar SVBY, Gupte N, Babu S, Salvi S, Golub J, Checkley W, Bollinger RC, Andrade B, Mave V, Chandrasekaran P, Gupta A. IL-6, TIMP-2 and TGFβ-2 are associated with respiratory...

Impact of Fogarty HIV-TB Training Program on ‘Institutional Research Capacity Building’ at the Byramjee Jeejeebhoy Government Medical College (BJGMC), Pune, India

Post Date: 
2018-10-27
   |   
Clinical Sites: 
BJGMC
Dhumal G, DeLuca A, Chandanwale A, Kadam D, Joshi S, Kinikar A, Suryavanshi N, Mave V, Gupta A, Bollinger R. Impact of Fogarty HIV-TB Training Program on ‘Institutional Research Capacity Building’ at the Byramjee Jeejeebhoy Government Medical College (BJGMC), Pune, India. Session: Building...

Utility of QGIT as an Adjunct to TST for Screening of Latent Tuberculosis Infection among Indian Healthcare Workers

Post Date: 
2018-10-26
Girish S, Kinikar A, Pardeshi G, Shelke S, Basavaraj A, Chandanwale A, Gupte N, Bollinger R. Utility of QGIT as an Adjunct to TST for Screening of Latent Tuberculosis Infection among Indian Healthcare Workers. 49th Annual Union World Conference on Lung Health. The Hague, The Netherlands. October 24...

High Prevalence of Dengue among Pregnant Women in India

Post Date: 
2018-08-27
   |   
Countries: 
India
   |   
Clinical Sites: 
BJGMC
Alexander M, Naik S, Robinson M , Sapkal G, Deshpande P, Kulkarni V, Nimkar S, Sambarey P, Kinikar A, Mave V, Suryavanshi N, Gupte N, Bollinger R, Gupta A, Bharadwaj R, Mathad J. High Prevalence of Dengue among Pregnant Women in India. 2018 International Conference on Emerging Infectious Diseases...

Mobile Health and Behavioral PMTCT Intervention among Community Health Workers Improves Exclusive Breastfeeding and Early Infant Diagnosis in India: A Cluster Randomized Trial

Post Date: 
2018-07-24
   |   
Countries: 
India
   |   
Clinical Sites: 
BJGMC
Suryavanshi N, Kadam A, Hegde A, Sivalenka S, Kumar VS, McKenzie-White J, Kanade S, Gupta A, Bollinger RC, Shankar A, Gupte N, Mave V. Mobile Health and Behavioral PMTCT Intervention among Community Health Workers Improves Exclusive Breastfeeding and Early Infant Diagnosis in India: A Cluster...

Inflammation in HIV-Infected Pregnant Women is Associated with Pre-term Birth

Post Date: 
2018-03-07
   |   
Countries: 
India
   |   
Clinical Sites: 
BJGMC
Shivakoti R , Gupte N, Kumar NP, Kulkarni V, Balasubramanian U, Bhosale R, Sambarey P, Kinikar A, Bharadwaj R, Patil S, Inamdar S, Suryavanshi N, Babu S, Bollinger R, Gupta A. Inflammation in HIV-Infected Pregnant Women is Associated with Pre-term Birth. CROI 2018. Boston, MA. 2018

High Burden of Genital TB Among Women with Infertility in India - Need for an Intensified Approach

Post Date: 
2017-10-13
   |   
Clinical Sites: 
BJGMC
Naik SN , Chandanwale A, Joshi S, Mave V, Dhumal G, DeLuca A, Gupta A, Bollinger R. High Burden of Genital TB Among Women with Infertility in India - Need for an Intensified Approach. 48th Annual Union World Conference of Lung Health. Guadalajara, Mexico. October 13, 2017.

A Study to Compare Efficacy of Oral High Dose Rifampicin with Standard Dose Rifampicin in Tuberculous Meningitis

Post Date: 
2017-10-13
   |   
Clinical Sites: 
BJGMC
Basavaraj A , Avhad A, Kadam D. A Study to Compare Efficacy of Oral High Dose Rifampicin with Standard Dose Rifampicin in Tuberculous Meningitis. 48th Annual Union World Conference of Lung Health. Guadalajara, Mexico. October 13, 2017.

Prevalence of Vitamin D Deficiency among Indian Children with Tuberculosis and Age- and Sex-matched Controls

Post Date: 
2017-10-13
   |   
Clinical Sites: 
BJGMC
Kinikar A , Chandanwale A, Dixit S, Jubilus J, Jain S, Bharadwaj R, Mave V, Gupte N, DeLuca A, Gupta A, Bollinger RC. Prevalence of Vitamin D Deficiency among Indian Children with Tuberculosis and Age- and Sex-matched Controls. 48th Annual Union World Conference of Lung Health. Guadalajara, Mexico...

Delays and Barriers to Early Treatment Initiation for Childhood Tuberculosis in India

Post Date: 
2017-10-13
   |   
Clinical Sites: 
BJGMC
Valvi C , Chandanwale A, Khadse A, Kulkarni R, Kadam D, Dhumal G, Bollinger RC, Deluca A. Delays and Barriers to Early Treatment Initiation for Childhood Tuberculosis in India. 48th Annual Union World Conference of Lung Health. Guadalajara, Mexico. October 13, 2017.

Barriers to Contact Screening and Isoniazid Preventive Therapy among Pediatric Contacts of Adults with Smear-positive Tuberculosis

Post Date: 
2017-10-12
   |   
Clinical Sites: 
BJGMC
Belgaumkar V , Chandanwale A, Valvi C, Khadse S, Jain D, Dhumal G, Bollinger RC, Deluca A. Barriers to Contact Screening and Isoniazid Preventive Therapy among Pediatric Contacts of Adults with Smear-positive Tuberculosis. 48th Annual Union World Conference of Lung Health. Guadalajara, Mexico.

Delays and Barriers to Early Treatment Initiation in Childhood Tuberculosis in India

Post Date: 
2017-10-11
   |   
Countries: 
India
Valvi C, Chandanwale A, Khadse S, Kulkarni R, Kadam D, Dhumal G , Deluca A, Bollinger RC. Delays and Barriers to Early Treatment Initiation in Childhood Tuberculosis in India. The 48th Union World Conference on Lung Health. Guadalajara, Mexico.

Lack of TB Knowledge among TST positive Household Contacts of Pulmonary Cases: A Missed Opportunity

Post Date: 
2017-10-11
   |   
Countries: 
India
DeLuca, A., Dhumal, G., Paradkar, P., Suryavanshi, N., Mave, V., Kohli, K., Shivakumar, S., Gupta. A. Lack of TB Knowledge among TST positive Household Contacts of Pulmonary Cases: A Missed Opportunity. The 48th Union World Conference on Lung Health. Guadalajara, Mexico.

High Burden of Diabetes and Prediabetes among Adult Household Contacts of India

Post Date: 
2017-09-13
   |   
Countries: 
India
   |   
Clinical Sites: 
BJGMC
NIRT
Shivakumar SVBY , Chandrasekaran P, Kumar AJMV, Paradkar M, Dhanasekaran K, Suryavanshi N, Thomas B, Kohli R, Thiruvengadam K, Kulkarni V, Hannah LE, Sivaramakrishnan GN, Pradhan N, Dolla C, Gupte A, Ramachandran G, DeLuca A, Meshram S, Bhardawaj R, Bollinger RC, Golub J, Selvaraj K, Gupte N,...

How Americans Benefit from Global Health Research

Post Date: 
2017-05-25
   |   
Countries: 
India
Bollinger, R. How Americans Benefit from Global Health Research. The Fogarty International Center: How Americans Benefit from Global Health Research Webinar, Research!America. Washington, DC.

Outreach Workers in the Prevention of Mother to Child Transmission of HIV (PMTCT) Programme in India: Challenges and Opportunities

Post Date: 
2016-07-21
   |   
Countries: 
India
   |   
Clinical Sites: 
BJGMC
Suryavanshi N , Mave V, Kadam A, Kanade S, Sivalenka S, Sampath K, Harve P, Gupta RS, Hegde A, McKenzie-White J, Gupte N, Gupta A, Bollinger RC, Shankar AV. Outreach Workers in the Prevention of Mother to Child Transmission of HIV (PMTCT) Programme in India: Challenges and Opportunities. 21st...

High TB Risk in HIV-Positive Patients on Second line Antiretrovirals in Pune, India

Post Date: 
2016-02-24
   |   
Countries: 
India
Mave V , Kadam D, Salvi S, Basavaraj A, Joshi S, Chandanwale A, Gupte N, Bollinger RC, Gupta A. High TB Risk in HIV-Positive Patients on Second line Antiretrovirals in Pune, India. Conference on Retroviruses and Opportunistic Infections 2016. Boston, MA. 2016.

TB Risk Perceptions Among Medical Residents at a Tertiary Care Center in India

Post Date: 
2015-12-06
   |   
Countries: 
India
Pardeshi G , Parande M, Kadam D, Chandanwale A, Deluca A, Bollinger R, Farley J, Suryavanshi N. TB Risk Perceptions Among Medical Residents at a Tertiary Care Center in India. 46th Union World Conference on Lung Health. International Union for Tuberculosis and Lung Disease. Cape Town, South Africa.

Pages

Dr. Shilpa Naik: Obstetrics and Gynecology

BJGMC-JHU Fogarty HIV-TB Program Trainee
Pune, India
I am working as an Associate Professor & Unit Incharge since 2009 in the Department of Obstetrics & Gynecology at B.J.Govt Medical College & Sassoon General Hospitals Pune. I have been managing High Risk Obstetrics and has keen interest in Critical Care Obstetrics.

Akshay Gupte, PhD, MBBS, MSPH

Junior Investigator
Akshay Gupte
Akshay Gupte is a junior investigator trained in medicine, clinical research, and global health. His research interests include exploring approaches to host directed adjuvant therapies in tuberculosis (TB) and studying the impact of TB and HIV on lung health of populations. Dr. Gupte leads an Indo-US collaborative study exploring the impact of TB disease; alone and in combination with smoking, air pollution, HIV and diabetes mellitus; on respiratory impairment and risk of chronic obstructive pulmonary disease in India. He is also a co-investigator on the CTRIUMPH study—a multi-center cohort...

Akshay Gupte, PhD, MBBS, MSPH

Instructor of Medicine
Akshay Gupte
Dr. Gupte is Instructor of Medicine at CCGHE. He is trained in medicine, clinical research, and global health. He recently completed his doctoral training in the Department of International Health at the Johns Hopkins Bloomberg School of Public Health (JHSPH). His research interests include exploring approaches to host directed adjuvant therapies in tuberculosis (TB) and studying the impact of TB and HIV on lung health of populations. Dr. Gupte leads an Indo-US collaborative study exploring the impact of TB disease alone, and in combination with smoking, air pollution, HIV and diabetes...

Jeff Tornheim, MD, MPH

Infectious Disease Fellow
Baltimore, Maryland
Jeff Tornheim, MD, MPH, is a clinical fellow in the Division of Infectious Disease here at Johns Hopkins University School of Medicine. After completing undergraduate studies in International Development and Economics at Brandeis University he moved to East Africa where he engaged in health system strengthening for returning refugees to South Sudan and worked with the Centers for Disease Control and Prevention (CDC) on the epidemiology of pneumonia and diarrhea in Western Kenya. He completed a joint MD/MPH at Mount Sinai School of Medicine, with his thesis evaluating the impact of water...

Aarti Avinash Kinikar, MD: Pediatrics

BJGMC-JHU Fogarty HIV-TB Program Trainee
Pune, India
Education : MBBS (1984); DCH (1988); MD-Paediatrics (1988), DNB-Paediatrics (2003); MRCP-UK (1995). Medical Education- Grant Medical College – Mumbai University, India.

Amit Kale, MS: Orthopedics

BJGMC-JHU Fogarty HIV-TB Program Trainee
Pune, India
I am working as associate professor in orthopedics. Currently, I am conducting various drug trials for rheumatoid arthritis.

Anita Basavaraj, MD: Gastroenterology

BJGMC-JHU Fogarty HIV-TB Program Trainee
Pune, India
Dr Anita Basavaraj has done her MBBS from Nagpur University with Honors in Surgery (1987). Thereafter she did her MD in Medicine (1990) and her Diplomat of National Board (D.N.B.) in 1992.She has done her post graduate Diploma in geriatric Medicine (P.G.D.G.M.) winning the university Gold Medal by virtue of standing first in the country (2012), which is a distant education venture run by Indira Gandhi National Open University (IGNOU).

Geeta Shrikar Pardeshi, MD: Preventive and Social Medicine

BJGMC-JHU Fogarty HIV-TB Program Trainee
Pune, India
I have led research projects related to Reproductive and Child Health, Sanitation and Infectious diseases. As part of the BJGMC JHU Fogarty training program in HIV-TB, I have research interest in TB epidemiology. I am interested in studying the association of co-morbidities with clinical presentation and treatment outcomes in tuberculosis.

Sunita Girish, PhD: Medical Biochemistry

BJGMC-JHU Fogarty HIV-TB Program Trainee
Pune, India
Education : Ph.D, Pune University, 2005 (Medical Biochemistry) title “Antioxidant Status in Leprosy.” Overview : How to improve health systems to combat various infectious diseases like Leprosy, Tuberculosis and HIV in developing countries, is a research and policy issue that affects many aspects of public health. My research interests include further to understand molecular level changes in cystic fibrosis which is under diagnosed .My interests also involve innovations in molecular techniques dealing with infectious diseases, help governments in developing countries to improve and modify...

Sangita Shelke, MD: Preventive and Social Medicine; Diplomas in Nutrition, Hospital Administration, Psychological counseling

BJGMC-JHU Fogarty HIV-TB Program Trainee
Pune, India
Indeed TB is a social disease with so many social problems especially the women suffering from TB/HIV undergoes a pathetic life situation. Women are silent suffers, of both HIV and TB in male dominated society of India. My ultimate desire is if I can make a difference in the lives of these silent suffers.

Dr. Smita Deshpande: Microbiology

BJGMC-JHU Fogarty HIV-TB Program Trainee
My research interests have been: Rapid diagnostic methods for Acute pyogenic meningitis, Diagnosis of enteric fever , Role of Methicillin resistance Staph aureus in infections, Molecular diagnosis of Leptospirosis, Rapid diagnosis of MDR-TB by REMA ( Resasurine Micro titre Plate Assay)and by Line Probe Assay.

Dr. Chhaya Valvi: Pediatrics

BJGMC-JHU Fogarty HIV-TB Program Trainee
Pune, India
Dr. Chhaya Valvi has completed her undergraduate and postgraduate medical education from the premier institute of Seth G.S. Medical College, Mumbai, India. She was awarded the prestigious Dr. Palekar prize as she ranked first among the candidates for M.D. exam.

Dr. Vasudha Belgaumkar: Dermatology

BJGMC-JHU Fogarty HIV-TB Program Trainee
Pune, India
Dr.Vasudha has completed her undergraduate medical education from S.B.H. Government Medical College, Dhule,Maharashtra .A meritorious student throughout, she topped her first and final year University examinations. She is presently working as Associate Professor of Dermatology at B.J. Government Medical College, Pune. Having completed her post-graduation in Dermatology, Venereology (including HIV) and Leprology from this premier institute, she has acquired clinical skills as well as an affinity for research.

Rahul Lokhande, MD: Pulmonary Medicine

BJGMC-JHU Fogarty HIV-TB Program Trainee
Pune, India
He is Unit In charge at B J Government Medical college and Sassoon Hospital Pune . He has special Interest in Bronchoscopy and Respiratory Intensive Care Unit of Sassoon Hospital.

World Renowned Infectious Disease Doctor on New COVID-19 Vaccines and Recommended Thanksgiving Precautions

Post Date: 
2020-11-23
Source: 
The Leslie Marshall Show
Dr. Robert Bollinger
Leslie Marshall Show: Dr. Bollinger provides updates about the COVID-19 pandemic and issues a holiday travel warning.

Leslie Marshall interviews Dr. Bob Bollinger on Latest COVID-19 News, Including Vaccines

Post Date: 
2020-10-07
Source: 
The Leslie Marshall Show
Dr. Robert Bollinger
CCGHE's Bob Bollinger talks with Leslie Marshall about the latest COVID-19 news, including vaccines.

Global Pandemic: The Value of Telemedicine and Concerns with Returning to School

Post Date: 
2020-08-20
Source: 
Fox News Rundown
Dr. Robert Bollinger
Fox News Rundown : Dr Bob Bollinger dicusses the uptick and importance of telemedicine during the pandemic and concerns with schooling.

Research Story Tip: International Johns Hopkins Study Says Broad Measures Needed to Prevent TB Spread in India

Post Date: 
2020-08-06
Dr. Mandar Paradkar
Johns Hopkins News Release: News release highlights study findings published in PLOS One by Dr. Mandar Paradkar and colleagues.

Broad measures needed to check spread of TB in India, say researchers

Post Date: 
2020-08-05
Source: 
The Tribune (India)
Drs. Mandar Paradkar and Robert Bollinger are quoted in this article that highlights their recent paper about administration of TB preventive therapy for household contacts of confirmed TB cases in India.

Can We Reverse the Pandemic’s Deadly Trajectory Before it is Too Late?

Post Date: 
2020-07-20
Source: 
Background Briefing with Ian Masters
Dr. Robert Bollinger
Background Briefing : Bob Bollinger discusses the US response to COVID-19 with Ian Masters and what we could have learned from European countries.

Why the Virus is Winning

Post Date: 
2020-07-16
Source: 
The Mark Levine Show
Dr. Robert Bollinger
The Mark Levine Show : Bob Bollinger discusses the COVID-19 situation in the US, and why the virus is spreading so quickly.

World Renowned Infectious Disease Doctor Talks Latest COVID-19 News

Post Date: 
2020-06-26
Source: 
The Leslie Marshall Show
Robert Bollinger
Leslie Marshall Show: Bob Bollinger discusses COVID-19 and the state of the epidemic in the US.

The Coronavirus Isn't Gone. An Expert Answers Your Questions

Post Date: 
2020-06-25
Source: 
Spectrum News NY1
Robert Bollinger
NY1 News : Bob Bollinger discusses a wide range of issues related to COVID-19 testing, immunity and transmission in this broadcast.

Dr. Robert Bollinger on the Coronavirus Pandemic

Post Date: 
2020-06-12
Source: 
C-SPAN
Robert Bollinger
C-SPAN, Washington Journal: Dr. Bob Bollinger fielded viewer questions on COVID-19 during this hour-long broadcast.

Coronavirus: Is herd immunity possible and if so, what’s the threshold?

Post Date: 
2020-06-04
Source: 
FOX News (Via Yahoo! News)
Robert Bollinger
FOX News: Dr. Bob Bollinger discusses COVID-19 and the use of masks, infection, and antibody testing

UK coronavirus death toll is now the highest in Europe

Post Date: 
2020-05-05
Source: 
BBC World News Radio: Newshour
Dr. Robert Bollinger
BBC: World News Radio : Bob Bollinger discusses COVID infection, mortality, and disease spread.

World Renowned Infectious Disease Doctor on COVID-19 Testing Policy

Post Date: 
2020-05-04
Source: 
Leslie Marshall Show
Dr. Robert Bollinger
CCGHE Director Dr. Bob Bollinger is interviewed.

The Covid-19 Riddle: Why Does the Virus Wallop Some Places and Spare Others?

Post Date: 
2020-05-03
Source: 
New York Times
Dr. Robert Bollinger was interviewed for this article "[young people] are less likely to have certain health problems that can make Covid-19, the disease caused by the coronavirus, particularly deadly, according to the World Health Organization."

Want to end state lockdowns? Send in the coronavirus detectives.

Post Date: 
2020-04-21
Source: 
The Christian Science Monitor
Contact Tracing
CSM: Bob Bollinger discusses limitations in US capacity for tracing contacts of confirmed COVID-19 cases.

Crowd-Sourcing COVID-19 Knowledge: Doctors turn to social media

Post Date: 
2020-04-16
Source: 
NBC News (via WDTN, Dayton, OH)
Approved followers can see videos of nurses teaching others how to safely roll over a patient, or how to use a ventilator. Dr. Bob Bollinger of Johns Hopkins says medicine is changing. “I think it can be a very important tool, but it has to be leveraged in a way that it supports the other parts of...

Coronavirus live blog: Infectious disease expert Dr. Bob Bollinger answers your questions

Post Date: 
2020-04-10
Source: 
Fox News
Dr. Bob Bollinger, a professor of infectious diseases at the Johns Hopkins University School of Medicine, and consultant at emocha, a digital health startup using telehealth to monitor healthcare providers for COVID-19 symptoms.

Economy CANNOT restart until testing and contact tracing improves, says John Hopkins expert

Post Date: 
2020-04-09
Source: 
Brinkwire
The US economy cannot restart until testing and contact tracing for the killer disease improves, according to a John Hopkins infectious disease expert. Dr. Robert Bollinger of Johns Hopkins University warned that the ‘biggest issue’ in the fight against the pandemic is the...

Without Testing We Do Not Know Where the Virus is and Who Has It

Post Date: 
2020-04-09
Source: 
Background Briefing with Ian Matthews
We begin with the U.S. having close to 500,000 COVID-19 cases, by far the highest in the world, and at the same time one of the lowest rates of testing for the virus with less that 1% of the population tested so far. Dr. Robert Bollinger, Professor of Infectious Diseases at The Johns Hopkins...

US needs more testing to ‘transfer the economy ahead,’ says Johns Hopkins infectious disease expert

Post Date: 
2020-04-09
Source: 
Gruntstuff
Dr. Robert Bollinger, CCGHE Director, was interviewed for this report on the COVID-19 pandemic. Particularly, the U.S. needs more speedy testing and a greater system of contact tracing to decide who has been contaminated by COVID-19 and who has not, Bollinger mentioned on “Energy...

Pages